TRAZODONE HYDROCHLORIDE
- Product NDC
- 64980-675
- 11-digit product format
- 649800675
- Labeler code
- 64980
- Product ID
- 64980-675_ab9a16ff-7bca-4445-b6e5-5122e097995c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- trazodone hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Rising Pharma Holdings, Inc.
- Application
- ANDA217740
- Marketing category
- ANDA
- Marketing start
- 2025-01-29
- Substance
- TRAZODONE HYDROCHLORIDE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Serotonin Reuptake Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- TRAZODONE HYDROCHLORIDE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TRAZODONE HYDROCHLORIDE | 300 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 6E8ZO8LRNM |
| Rxcui | 856364, 856369, 856373, 856377 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 64980-675-01 | TRAZODONE HYDROCHLORIDE | 100 in 1 BOTTLE | TABLET | 100 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 64980-675 | TRAZODONE HYDROCHLORIDE TABLET [RISING PHARMA HOLDINGS, INC.] | 2 | Current NDC, 1 package rows | 20250515_ef26e4f0-f31f-4efa-9938-28c886cf3d1d.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 64980-675-01 | 64980067501 | 100 TABLET in 1 BOTTLE (64980-675-01) | 100 tablet | 2025-01-29 | No | No | Historical |